PepGen Statistics
Total Valuation
PepGen has a market cap or net worth of $320.32 million. The enterprise value is $263.53 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PepGen has 68.74 million shares outstanding. The number of shares has increased by 20.11% in one year.
| Current Share Class | 68.74M |
| Shares Outstanding | 68.74M |
| Shares Change (YoY) | +20.11% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 17.88% |
| Float | 40.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.15 |
| P/TBV Ratio | 4.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.74, with a Debt / Equity ratio of 0.25.
| Current Ratio | 4.74 |
| Quick Ratio | 4.56 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -85.69% and return on invested capital (ROIC) is -48.76%.
| Return on Equity (ROE) | -85.69% |
| Return on Assets (ROA) | -43.44% |
| Return on Invested Capital (ROIC) | -48.76% |
| Return on Capital Employed (ROCE) | -119.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.20M |
| Employee Count | 81 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -617,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.09% in the last 52 weeks. The beta is 1.97, so PepGen's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | -34.09% |
| 50-Day Moving Average | 3.34 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 54.58 |
| Average Volume (20 Days) | 845,357 |
Short Selling Information
The latest short interest is 3.94 million, so 5.73% of the outstanding shares have been sold short.
| Short Interest | 3.94M |
| Short Previous Month | 5.17M |
| Short % of Shares Out | 5.73% |
| Short % of Float | 9.80% |
| Short Ratio (days to cover) | 0.46 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -102.77M |
| Pretax Income | -97.53M |
| Net Income | -96.92M |
| EBITDA | -101.29M |
| EBIT | -102.77M |
| Earnings Per Share (EPS) | -$2.97 |
Full Income Statement Balance Sheet
The company has $74.65 million in cash and $17.86 million in debt, giving a net cash position of $56.79 million or $0.83 per share.
| Cash & Cash Equivalents | 74.65M |
| Total Debt | 17.86M |
| Net Cash | 56.79M |
| Net Cash Per Share | $0.83 |
| Equity (Book Value) | 71.16M |
| Book Value Per Share | 2.17 |
| Working Capital | 61.13M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$90.02 million and capital expenditures -$581,000, giving a free cash flow of -$90.60 million.
| Operating Cash Flow | -90.02M |
| Capital Expenditures | -581,000 |
| Free Cash Flow | -90.60M |
| FCF Per Share | -$1.32 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PepGen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.11% |
| Shareholder Yield | -20.11% |
| Earnings Yield | -30.26% |
| FCF Yield | -28.28% |
Analyst Forecast
The average price target for PepGen is $9.17, which is 96.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.17 |
| Price Target Difference | 96.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -55.27% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |